Main menu
Edison Group
  • Home
  • Sparks
  • Equities

    Equities

    View All Equities

    Equities by Sector

    The Schiehallion Fund

    MCap

    USD2,216m

    Last close

    USD2.16

    ▲ 157.83 (7,273.27%)

    Eleco

    MCap

    GBP194m

    Last close

    GBP2.29

    ▲ 94.50 (70.26%)

    Metals One

    MCap

    —

    Last close

    GBP0.01

    ▲ 0.18 (19.44%)

  • Sectors

    Sectors

    View All Sectors
  • Megatrends

    Megatrends

  • Thematics

    Thematics

    View All Thematics

    Latest

  • Audiovisual

    Audiovisual

    View All Audiovisual

    Latest

KOL event – Lusvertikimab and the IL-7R pathway: An expert deep dive into IBD

KOL event – Lusvertikimab and the IL-7R pathway: An expert deep dive into IBD

OSE Immunotherapeutics — 10 videos in collection

More on this equity

This key opinion leader (KOL) webinar, hosted by OSE Immunotherapeutics, featured Laurent Peyrin-Biroulet, MD, PhD, (Nancy University Hospital, France) and Maia Kayal, MD, MS, (Icahn School of Medicine at Mount Sinai, New York), alongside Marc Le Bozec (CEO, OSE Immunotherapeutics). The event focused on lusvertikimab, OSE’s anti-IL-7R monoclonal antibody and lead immuno-inflammation asset. The discussion reviewed the targeting of the IL-7/IL-7R axis as a novel therapeutic approach for inflammatory bowel disease (IBD), the positive results from the Phase II CoTikiS study in ulcerative colitis and the planned expansion into chronic pouchitis. The KOLs expressed their encouragement regarding the CoTikiS results, and were supportive of the translation to chronic pouchitis, both in terms of lusvertikimab’s mode of action and the underlying disease biology.

< Previous

You may also be interested in these:

Healthcare

OSE Immunotherapeutics – equity proposition

Healthcare

OSE Immunotherapeutics – KOL event: Tedopi, most advanced therapeutic cancer vaccine
Cookie Policy Overview
Edison Group

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping us understand which section of the website you find more interesting and useful. See our Cookie Policy for more information.

Strictly necessary and functional

These cookies are used to deliver our website and content. Strictly necessary cookies relate to our hosting environment, and functional cookies are used to facilitate social logins, social sharing and rich-media content embeds.

Advertising

Advertising Cookies collect information about your browsing habits such as the pages you visit and links you follow. These audience insights are used to make our website more relevant.

Performance

Performance Cookies collect anonymous information designed to help us improve the site and respond to the needs of our audiences. We use this information to make our site faster, more relevant and improve the navigation for all users.